Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
Étude KIDES-203 : étude de phase 1, de première administration chez l’homme, en escalade dose, évaluant la tolérance d’ODM-203, un inhibiteur de VEGFR/FGFR, chez des patients ayant une tumeur solide avancée. [essai clos aux inclusions] https://kusajili.fr:443/Trial/n4nlHze8ZUGdrL4TOAFyGw%24etude-kides-203-etude-de-phase-1-de-premiere-administration-chez-lhomme-en-escalade-dose-evaluant-la-tolerance-dodm-203-un-inhi
I have read and accept the terms of use of the site and the Privacy Policy
Send your message